During the past decade, Mercy Health conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mercy Health" are "Ischemic Stroke" (3 trials), "Arrhythmias, Cardiac" (1 trials) and "Neovascularization" (1 trials). Many other conditions were trialed in "Mercy Health" in a lesser frequency.

Most popular intervention types in "Mercy Health" are "Device" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "CanGaroo Envelope" (1 trials), "Recanalization only" (1 trials), "Thermogard XP3" (1 trials), "Tigertriever 13" (1 trials) and "Tigertriever revascularization device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Health" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Health". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mercy Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".